Molemedd Plus Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 23-06-2024
- Paid Up Capital ₹ 2.50 Cr
as on 23-06-2024
- Company Age 10 Year, 14 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.00 Cr
as on 23-06-2024
- Revenue 10.34%
(FY 2022)
- Profit 38.08%
(FY 2022)
- Ebitda 4.06%
(FY 2022)
- Net Worth 37.14%
(FY 2022)
- Total Assets 16.39%
(FY 2022)
About Molemedd Plus
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.50 Cr.
The company has closed loans amounting to ₹6.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Jinnahally Venugopal and Murali Nadig serve as directors at the Company.
- CIN/LLPIN
U85110KA2014PTC077003
- Company No.
077003
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Oct 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Molemedd Plus?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jinnahally Venugopal  | Director | 30-Mar-2018 | Current |
| Murali Nadig | Director | 29-Oct-2014 | Current |
Financial Performance and Corporate Structure Insights of Molemedd Plus.
Molemedd Plus Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.34% increase. The company also saw a substantial improvement in profitability, with a 38.08% increase in profit. The company's net worth Soared by an impressive increase of 37.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Molemedd Plus?
In 2019, Molemedd Plus had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vishwam Health And Theranostics (Opc) Private Limited
Active 1 month 15 daysMurali Nadig is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 May 2016 | ₹1.20 Cr | Satisfied |
Srei Equipment Finance Limited Creation Date: 30 Jun 2015 | ₹4.80 Cr | Satisfied |
How Many Employees Work at Molemedd Plus?
Molemedd Plus has a workforce of 17 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Molemedd Plus, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Molemedd Plus's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
